Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection

Expert Opinion on Therapeutic Targets

Volumn 6, Issue 2, 2002, Pages 135-146

  Ge, Zhongming ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

A mouse model; Anthelmintics; Chemotherapies; Fumarate reductase; Gastric pathogen; Gene sequence and organisation; H. pylori; Vaccine

Indexed keywords

AMOXICILLIN; ANTHELMINTIC AGENT; ANTIBIOTIC AGENT; BISMUTH CITRATE; CLARITHROMYCIN; FUMARATE REDUCTASE; FUMARIC ACID; FURAZOLIDONE; HELICOBACTER PYLORI VACCINE; METRONIDAZOLE; MORANTEL; OMEPRAZOLE; OXANTEL; OXIDOREDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; TETRACYCLINE; TIABENDAZOLE;

ABDOMINAL PAIN; ANAEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CITRIC ACID CYCLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG COST; DRUG EFFICACY; ENERGY METABOLISM; GASTRITIS; GENOME ANALYSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELMINTHIASIS; HUMAN; IMMUNOGENICITY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NAUSEA; NONHUMAN; REVIEW; SIDE EFFECT; STOMACH CANCER; STOMACH ULCER; VOMITING;

EID: 0036249007     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.6.2.135     Document Type: Review

References (63)

1. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
2. NIC consensus development panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease
3. H. pylori and gastric cancer
4. Helicobacter pylori infection and gastric lymphoma
5. The complete genome sequence of the gastric pathogen Helicobacter pylori
6. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
7. Expression and functional properties of fumarate reductase
8. The tricarboxylic acid cycle of Helicobacter pylori
9. Metabolism and genetics of Helicobacter pylori: The genome era
10. Helicobacter pylori physiology predicted from genomic comparison of two strains
11. A systematic review of Helicobacter pylori eradication therapy - The impact of antimicrobial resistance on eradication rates
12. Therapy of Helicobacter pylori: Current status and issues
13. Review article: Treatment of Helicobacter pylori infection with ranitidine bismuth citrate or proton pump inhibitor-based triple therapies
14. Regular review: Treatment of Helicobacter pylori infection
15. Comparative efficacy of new investigational agents against Helicobacter pylori
16. Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori
17. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations
18. Genotypic characterization of clarithromycin -resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates
19. High prevalence of mixed infections by Helicobacter pylori in Hong Kong: Metronidazole sensitivity and overall genotype
20. Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori
21. Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: Prevalence and role of genes involved in metronidazole resistance
22. Clarithromycin versus furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate
23. Experience with 'triple' anti-Helicobacter pylori eradication therapy: Side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance
24. Antibiotic resistance in Helicobacter pylori: Implications for therapy
25. The design of vaccines against Helicobacter pylori and their development
26. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
27. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
28. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
29. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers
30. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection
31. Cloning and functional characterization of Helicobacter pylori fumarate reductase operon comprising three structural genes coding for subunits C, A and B
32. Wolinella succinogenes fumarate reductase contains a dihaem cytochrome b
33. The fumarate reductase operon of Wolinella succinogenes. Sequence and expression of the frdA and frdB genes
34. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences
35. A structural model for the membrane-integral domain of succinate:Quinone oxideoreductases
36. Physiological function and regulation of flavocytochrome c3, the soluble fumarate reductase from Shewanella putrefaciens NCIMB 400
37. Structure of fumarate reductase from Wolinella succinogenes at 2.2 Å resolution
38. Structure of the Escherichia coli fumarate reductase respiratory complex
39. Effect of cysteine to serine mutations on the properties of the (4Fe-4S) center in Escherichia coli fumarate reductase
40. Identification of active site residues of Escherichia coli fumarate reductase by site-directed mutagenesis
41. Essential role of Glu-C66 for menaquinol oxidation indicates transmembrane electrochemical potential generation by Wolinella succinogenes fumarate reductase
42. Deletion and site-directed mutagenesis of the Wolinella succinogenes fumarate reductase operon
43. Fumarate catabolism in Helicobacter pylori
44. Fumarate reductase: A target for therapeutic intervention against Helicobacter pylori
45. Fumarate reductase of Helicobacter pylori - An immunogenic protein
46. Molecular genetic analysis of FNR-dependent promoters
47. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: Repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance
48. Cloning and characterization of Helicobacter pylori succinyl CoA:acetoacetate CoA-transferase, a novel prokaryotic member of the CoA-transferase family
49. Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate:Flavodoxin and 2-oxoglutarate:Acceptor oxidoreductases which mediate electron transport to NADP
50. Another unusual type of citric acid cycle enzyme in Helicobacter pylori: The malate:Quinone oxidoreductase
51. Characterization of the respiratory chain of Helicobacter pylori
52. Anaerobic expression of Escherichia coli succinate dehydrogenase: Functional replacement of fumarate reductase in the respiratory chain during anaerobic growth
53. Characterization of fumarate transport in Helicobacter pylori
54. Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach
55. Nucleotide sequence and mutational analysis indicate that two Helicobacter pylori genes encode a P-type ATPase and a cation-binding protein associated with copper transport
56. Fumarate reductase of Escherichia coli: An investigation of function and assembly using in vivo complementation
57. Deletion and site-directed mutagenesis of the Wolinella succinogenes fumarate reductase operon
58. Helicobacter pylori requires fumarate reductase for acid resistance
59. Pharmacology of anthelmintics
60. The biochemical mode of action of some modern anthelmintics
61. Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulin
62. The interaction of benzimidazole carbamates with mammalian microtobule protein
63. Mebendazole and related anthelmintics